| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 73 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 54 |
| 2 | TACROLIMUS OINTMENT 0.1% | 54 |
| 3 | PREDNISONE | 23 |
| 4 | MYCOPHENOLATE MOFETIL | 22 |
| 5 | METHYLPREDNISOLONE | 19 |
| 6 | FLUCONAZOLE | 12 |
| 7 | INFLIXIMAB | 12 |
| 8 | SIROLIMUS | 9 |
| 9 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 1 | 0.0122 |
| 1 | BRINCIDOFOVIR | 1 | 0.0072 |
| 2 | GAS RELIEF | 1 | 0.0020 |
| 3 | SMOFLIPID | 1 | 0.0011 |
| 4 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 6 | 0.0007 |
| 5 | SIROLIMUS | 9 | 0.0007 |
| 6 | GANCICLOVIR SODIUM | 5 | 0.0005 |
| 7 | TACROLIMUS | 73 | 0.0005 |
| 8 | TACROLIMUS OINTMENT 0.1% | 54 | 0.0004 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 54 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 2 | GLP-2 Analog [EPC] | 3 | 0.0002 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 4 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 6 | Azole Antifungal [EPC] | 13 | 0.0001 |
| 7 | Purine Antimetabolite [EPC] | 7 | 0.0001 |
| 8 | Nucleoside Analog Antiviral [EPC] | 5 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |